An extraordinary thing happens to some patients with type 2 diabetes who undergo metabolic surgery: within days of the procedure and even before weight loss occurs, insulin production improves and the need for diabetes medication is dramatically reduced or eliminated altogether.
Around 3.6m people in the UK suffer from type 2 diabetes, which costs the NHS up to £10bn a year to treat.
Members of the Medical Journalists’ Association and Guild of Health Writers are being offered exclusive access to a meeting where two internationally renowned UK experts will deliver ground breaking news on new developments on curative surgery, what this means for the UK and the inside perspective on the current inequalities in patient access to care, as well as a picture of life before and after type 2 diabetes.
The event is organised by Medtronic starting at 6pm on Thursday, June 29 at The Wellcome Collection, The Burroughs Room, 183 Euston Rd, Bloomsbury, London NW1 2BE.
Professor Rachel Batterham
Professor of Obesity, Diabetes and Endocrinology, NIHR Research Professor UCLH Bariatric Centre for Weight Management & Metabolic Surgery
And presenter of recent BBC documentary ‘Obesity: How Prejudiced is the NHS?’
Professor Batterham is a global expert in the “Disease of Obesity” and its life threatening co-morbidities including Type 2 Diabetes. She will talk about the work that needs to be done to allow fair and equitable access to care and the necessity for any treatment pathways to include surgery if we are to counter the current global pandemic. Professor Batterham will introduce:
- What is type 2 diabetes and how is it caused?
- The prevalence of type 2 diabetes, its costs and impact on the healthcare system
- Current access to care, prevention and treatment, and future requirements
Professor Francesco Rubino
Chair of Bariatric and Metabolic Surgery, King’s College London and author of the ground breaking paper “Time to Think Differently About Diabetes” in the 2016 edition of Nature as well as contributor to BBC’s Inside Out London documentary on metabolic surgery
Professor Rubino has been at the forefront of research and the development of metabolic surgery for two decades. He believes surgery is “the closest thing to a cure” and thousands of patients with type 2 diabetes are being denied the chance of life-saving surgery because they do not fit strict NHS guidelines on weight. Professor Rubino will introduce:
- Why is the UK trailing behind Europe on treatment?
- American Diabetes Association guidelines – what are they and what do they mean for the UK?
- Evidence for surgery and its impact on type 2 diabetes
In addition to the Professors, we will also hear from a patient and former sufferer of type 2 diabetes with experience of metabolic surgery, representing the patient community.
Following the talks there will be a networking opportunity with speakers and peers over refreshments.
This invitation is offered as a resource for MJA members and the Association has been paid to distribute this invitation.